INNOVATING SCIENCE, INSPIRING GROWTH
HiMedia, driven by advanced in-house R&D, is India’s first globally recognised biosciences brand. It pioneers innovations across microbiology, cell biology, molecular biology, immunology, animal health, hydroponics, and agro-biotechnology, reflecting India’s rising prominence in the global biosciences sector.
In 1974, a visionary microbiologist Dr. Gangadhar M. Warke, along with his wife Mrs. Saroj G. Warke and brother Mr. Vishnu M. Warke, founded HiMedia as a modest venture to provide affordable culture media. Over the past five decades, the organisation has evolved into a global enterprise that develops, manufactures, and markets over 30,000 bioscience products. Headquartered in Mumbai, HiMedia has established offices and warehouses in Europe, the USA, and Brazil, ensuring seamless accessibility for scientists, researchers, and healthcare professionals across the globe. It has a strong presence in over 150 international markets, including Japan, Brazil, the Middle East, the USA, and Africa.
PRIDE OF GLOBALLY RENOWNED INDIAN R&D
Celebrated as the “Pride of India,” HiMedia revolutionises research by replacing expensive imports with high-quality, affordable products. By channeling profits into R&D, the company drives innovation and technological excellence. It is currently undertaking a fivefold expansion of ready-prepared culture media plate production.
GLOBAL SCIENCE, INDIAN INGENUITY
HiMedia’s serum-free and animal-component-free cell culture media, such as HEKin1TM and CELLin1TM, supports global vaccine production against diseases like COVID-19 and Foot-and-Mouth Disease. Its cell biology wing pioneers bioink development for 3D bio-printing and media cultivated meat manufacture. During the pandemic, HiMedia played a vital role by producing and supplying Swab Sample Collection Kits, Viral RNA Extraction Kits, and Multiplex PCR Detection Kits. Its innovations include Insta NX® Mag, India’s first CDSCO-approved automated platform for rapid nucleic acid extraction, capable of processing up to 96 samples in 11–30 minutes, and the Insta NX® Geno series, a flexible PCR workstation for automated workflows. Its HiPetriSlimTM plates have improved microbial testing efficiency in food and pharmaceutical industries, while its range of HiVeg products, high-quality ready prepared media, including HiCrome®, enable rapid & precise microbial differentiation through chromogenic technology. Partnering globally in probiotic research and advanced instrumentation like ANOXOMAT® III and MALDI-TOF MS, HiMedia drives innovation in microbial identification and empowers researchers with next-generation microbiological solutions.
HiMedia is advancing intuitive medicine with PCR-based antimicrobial resistance detection kits, bioinformatics for sequencing, gene mapping, and AI diagnostics, while its Higronics division supports smart and hydroponic farming.
DRIVING CHANGE THROUGH CSR
HiMedia drives social impact through CSR programs supporting regenerative medicine, healthcare, rural education via Ishavidya, and STEM outreach. The company has further strengthened its research-based initiatives by collaborating with IIT Bombay’s Wadhwani Research Centre for Bioengineering to launch the WRCB-HiMedia Bio-Innovation Laboratory.
GARNERING ACCOLADES
HiMedia’s committment to innovation and excellence has earned it several prestigious accolades such as the Hurun Award 2024, BioSpectrum’s Best Innovator for COVID-19 Solutions, and the BIRAC Innovator Award-2020. The organisation has also been recognised amongst the top 3 global microbiology media manufacturers by the prestigious ‘American Society of Microbiology’, in their ‘Handbook of Microbiological Media.’ It has also received the Rajiv Gandhi National Quality Award for outstanding quality and innovation.
